Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma

Dermatol Surg. 2005 Feb;31(2):217-20. doi: 10.1111/j.1524-4725.2005.31052.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Basal Cell / pathology
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Female
  • Gels
  • Humans
  • Male
  • Microscopy / methods
  • Middle Aged
  • Nicotinic Acids / administration & dosage
  • Nicotinic Acids / therapeutic use*
  • Predictive Value of Tests
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Gels
  • Nicotinic Acids
  • tazarotene